• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: A case report
Explor Res Clin Soc Pharm. 2023 Aug 24;11:100324. doi: 10.1016/j.rcsop.2023.100324. eCollection 2023 Sep.ABSTRACTThis case report describes the pharmacist intervention with a 62-year-old woman who had postmenopausal breast cancer. The patient was experiencing severe vasomotor symptoms from her cancer therapy and wanted to discontinue her treatment despite her risk of cancer returning. Using guidelines for treatment of postmenopausal breast cancer and medication options to mitigate vasomotor symptoms, the pharmacist developed a treatment plan that was acceptable to the patient and approved by the oncologist. Following imple...
Source: Clinical Breast Cancer - September 11, 2023 Category: Cancer & Oncology Authors: Megan R Undeberg Alanda Barash Kimberly C McKeirnan Source Type: research

The Relationship Between Taste and Smell Alterations and Quality of Life Among Women With Breast Cancer Receiving Chemotherapy
Oncol Nurs Forum. 2023 Jun 15;50(4):499-508. doi: 10.1188/23.ONF.499-508.ABSTRACTOBJECTIVES: To understand taste and smell alterations (TSAs) and their relationship with quality of life among women with breast cancer receiving chemotherapy.SAMPLE & SETTING: A descriptive correlational study was conducted with 121 women with breast cancer receiving chemotherapy, and data were collected through an online survey.METHODS & VARIABLES: The Taste and Smell Survey was used to measure TSAs, and the Functional Assessment of Cancer Therapy-Breast was used to measure quality of life.RESULTS: More than half of the participants ...
Source: Oncology Nursing Forum - September 7, 2023 Category: Nursing Authors: Hae Jeong An Sook Jung Kang Source Type: research

Role of cancer-educated mesenchymal stromal cells on tumor progression
Biomed Pharmacother. 2023 Sep 1;166:115405. doi: 10.1016/j.biopha.2023.115405. Online ahead of print.ABSTRACTThe malignant tumor is the main cause of human deaths worldwide. Current therapies focusing on the tumor itself have achieved unprecedented benefits. Various pro-tumorigenic factors in the tumor microenvironment (TME) could abolish the effect of cancer therapy. Mesenchymal stromal cells (MSCs) are one of the substantial components in the tumor microenvironment, contributing to tumor progression. However, MSCs are not inherently tumor-promoting. Indeed, they acquire pro-tumorigenic properties under the education of t...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - September 3, 2023 Category: Drugs & Pharmacology Authors: Ting Liu Shuwei Guo Yong Ji Wei Zhu Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11